Big pharma starts to court the stem cell field; common gene variant linked to obesity; new insight into flu viruses

Published on Tuesday 29 July 2008 - 16:50

Summary :
Stem Cell Research Forbes' Matthew Herper heralds last week's deal between GlaxoSmithKline and the Harvard Stem Cell Institute as a landmark in the drug development world. Long an ethical minefield...
Read more

Information source

http://www.fiercebioresearcher.com/news/frontpage

Website description
Source for scientific breakthroughs, technologies and news in the biotech research industry. Sign up for a free weekly biotech research briefing today.

Articles published on this website : 1 / 7 days - 1 / 30 days

Miami researchers identify nine Alzheimer's genes Junk food linked to Alzheimer's Stem cell spin-offs merge with $18M in new Pfizer dumping heart disease focus in R&D restructuring An old drug promises to slow aging process

Other articles published on other websites on the same day

Elan, Wyeth shares fall on Alzheimer's study results http://www.marketwatch.com/ Wyeth & Elan Alzheimer’s Drug Disappoints http://www.pharmalot.com/ Elan, Wyeth Tout Drug-Trial Data http://online.wsj.com/ Tau drug shows early promise in Alzheimer's http://www.reuters.com/ Elan, Wyeth Shares Fall On Alzheimer's Study Results http://www.foxbusiness.com/ 'De-Tangling' Alzheimer's Drug Shows Promise http://empowher.com/ ICAD: Brain Atrophy Patterns May Aid Early Identification of Alzheimer's http://www.medpagetoday.com/ 'Fantastic' New Hope for Alzheimer's? http://abcnews.go.com/ Elan and Wyeth Present Encouraging Results from Phase 2 Clinical Trial of Bapineuzumab at International Conference on Alzheimer's Disease http://www.foxbusiness.com/ Experimental Alzheimer's drug shows early promise http://hosted.ap.org/